EMERGENT BIOSOLUTIONS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of ER4 for the last quarter is 278.41 M EUR, and it's 11.09% higher compared to the previous quarter. The net income of Q1 24 is 8.34 M EUR.